Sagimet Biosciences Inc. Series A Common Stock Cash Flow
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
2023
2022
2021
2020
2019
-24M
-28M
0M
5M
0M
-1M
38M
0M
86M
0M
0 %
0M
0M
-4M
75M
75M
0M
-24M
-24M
-30M
0M
2M
0M
4M
-32M
0M
0M
0M
-0 %
0M
0M
0M
0M
-57M
57M
-24M
-22M
-24M
0M
2M
1M
0M
0M
0M
10M
0M
-0 %
0M
0M
10M
57M
-12M
69M
-22M
-10M
-11M
0M
1M
0M
0M
0M
0M
69M
0M
-0 %
0M
0M
0M
69M
58M
10M
-10M
-11M
-14M
0M
3M
0M
1M
0M
0M
18M
0M
-0 %
0M
-3M
22M
10M
8M
2M
-11M
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
1Q2021
1Q2020
-7M
-8M
0M
1M
0M
0M
-20M
0M
4M
0M
-0 %
0M
0M
-4M
75M
-27M
102M
-7M
-4M
-6M
0M
2M
0M
1M
0M
0M
87M
0M
-0 %
0M
0M
0M
102M
83M
19M
-4M
-6M
-7M
0M
1M
0M
0M
13M
0M
-1M
0M
-0 %
0M
0M
-1M
19M
6M
12M
-6M
-7M
-7M
0M
1M
0M
-1M
19M
0M
0M
0M
-0 %
0M
0M
0M
12M
12M
0M
-7M
-7M
-7M
0M
1M
0M
-1M
5M
0M
0M
0M
-0 %
0M
0M
0M
0M
-2M
2M
-7M
-6M
-7M
0M
0M
0M
1M
4M
0M
0M
0M
-0 %
0M
0M
4M
2M
-2M
4M
-6M
-6M
-7M
0M
0M
0M
1M
0M
0M
0M
0M
-0 %
0M
0M
-41M
4M
-48M
52M
-6M
-5M
-9M
0M
0M
0M
4M
0M
0M
0M
0M
-0 %
0M
0M
0M
52M
-5M
57M
-5M
-5M
-6M
0M
1M
1M
-1M
0M
0M
11M
0M
-0 %
0M
0M
0M
75M
6M
69M
-5M
-3M
-4M
0M
0M
0M
1M
0M
0M
0M
0M
-0 %
0M
0M
0M
8M
-3M
10M
-3M